CVS Health Corporation (CVS.DE)
EUR 43.83
(1.78%)
EUR 43.83
(1.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 356.62 Billion | 322.46 Billion | 292.11 Billion | 268.7 Billion | 256.77 Billion | 194.57 Billion |
| Cost of Revenue | 303.34 Billion | 268.17 Billion | 240.06 Billion | 219.66 Billion | 211.24 Billion | 163.04 Billion |
| Gross Profit | 53.27 Billion | 54.29 Billion | 52.04 Billion | 49.04 Billion | 45.52 Billion | 31.53 Billion |
| Operating Expenses | 39.53 Billion | 38.21 Billion | 37.06 Billion | 35.13 Billion | 33.54 Billion | 21.36 Billion |
| Selling, General and Administrative Expenses | 39.2 Billion | 38.03 Billion | 36.8 Billion | 34.58 Billion | 32.69 Billion | 20.82 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 39.53 Billion | 38.21 Billion | 37.06 Billion | 35.13 Billion | 33.54 Billion | 4 Million |
| Cost and Expenses | 342.88 Billion | 306.38 Billion | 277.12 Billion | 254.79 Billion | 244.78 Billion | 184.4 Billion |
| Operating Income | 13.74 Billion | 16.25 Billion | 13.19 Billion | 13.91 Billion | 11.98 Billion | 4.02 Billion |
| Interest Expense | 2.65 Billion | 2.28 Billion | 2.5 Billion | 2.9 Billion | 3.03 Billion | 2.61 Billion |
| Income Tax Expense | 2.8 Billion | 1.46 Billion | 2.52 Billion | 2.56 Billion | 2.36 Billion | 2 Billion |
| Earnings before Tax | 11.17 Billion | 5.62 Billion | 10.42 Billion | 9.77 Billion | 8.99 Billion | 1.4 Billion |
| Net Income | 8.34 Billion | 4.31 Billion | 8 Billion | 7.17 Billion | 6.63 Billion | -594 Million |
| Earnings Per Share Basic | 6.47 | 3.14 | 6.00 | 5.48 | 5.10 | -0.57 |
| Earnings Per Share Diluted | 6.47 | 3.14 | 5.95 | 5.46 | 5.08 | -0.57 |
| Weighted Average Shares Outstanding | 1.28 Billion | 1.31 Billion | 1.31 Billion | 1.3 Billion | 1.3 Billion | 1.04 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.29 Billion | 1.32 Billion | 1.32 Billion | 1.31 Billion | 1.3 Billion | 1.04 Billion |
| Gross Margin | 0.15 | 0.17 | 0.18 | 0.18 | 0.18 | 0.16 |
| EBIT Margin | 0.05 | 0.06 | 0.07 | 0.07 | 0.06 | 0.07 |
| Profit Margin | 0.02 | 0.01 | 0.03 | 0.03 | 0.03 | -0.00 |
| EBITDA | 18.43 Billion | 19.96 Billion | 18.64 Billion | 18.1 Billion | 16.18 Billion | 12.76 Billion |
| Earnings Before Tax Margin | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.02 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 91.23 Billion | 88.43 Billion | 357.77 Billion | 93.81 Billion | 89.76 Billion | 88.92 Billion |
| Cost of Revenue | 77.85 Billion | 75.87 Billion | 303.34 Billion | 79.93 Billion | 76.18 Billion | 75.31 Billion |
| Gross Profit | 13.38 Billion | 12.56 Billion | 54.43 Billion | 13.87 Billion | 13.57 Billion | 13.6 Billion |
| Operating Expenses | 10.33 Billion | 10.29 Billion | 39.83 Billion | 10.5 Billion | 9.87 Billion | 9.87 Billion |
| Selling, General and Administrative Expenses | 10.33 Billion | 10.29 Billion | - | 10.17 Billion | 9.78 Billion | 9.71 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 24 Million | 25 Million | 88 Million | 22 Million | 22 Million | 22 Million |
| Cost and Expenses | 88.18 Billion | 86.16 Billion | 343.17 Billion | 90.44 Billion | 86.06 Billion | 85.19 Billion |
| Operating Income | 3.04 Billion | 2.27 Billion | 13.74 Billion | 3.37 Billion | 3.69 Billion | 3.23 Billion |
| Interest Expense | 732 Million | 716 Million | 2.65 Billion | 690 Million | 693 Million | 686 Million |
| Income Tax Expense | 569 Million | 456 Million | 2.8 Billion | 658 Million | 754 Million | 656 Million |
| Earnings before Tax | 2.33 Billion | 1.58 Billion | 11.17 Billion | 2.7 Billion | 3.01 Billion | 2.57 Billion |
| Net Income | 1.77 Billion | 1.11 Billion | 8.34 Billion | 2.04 Billion | 2.26 Billion | 1.9 Billion |
| Earnings Per Share Basic | 1.41 | 0.88 | - | 1.59 | 1.76 | 1.48 |
| Earnings Per Share Diluted | 1.41 | 0.88 | - | 1.58 | 1.75 | 1.48 |
| Weighted Average Shares Outstanding | 1.25 Billion | 1.26 Billion | 1.28 Billion | 1.28 Billion | 1.28 Billion | 1.28 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.25 Billion | 1.26 Billion | 1.29 Billion | 1.29 Billion | 1.29 Billion | 1.28 Billion |
| Gross Margin | 0.15 | 0.14 | 0.15 | 0.15 | 0.15 | 0.15 |
| EBIT Margin | 0.05 | 0.04 | - | 0.05 | 0.05 | 0.05 |
| Profit Margin | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 |
| EBITDA | 4.22 Billion | 3.43 Billion | - | 4.52 Billion | 4.85 Billion | 4.85 Billion |
| Earnings Before Tax Margin | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 |
3848
DISI
SRSCQ
APURE
3521
GZPZY